focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

2 Jul 2019 07:00

RNS Number : 1145E
InnovaDerma PLC
02 July 2019
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma", the "Company" or the "Group")

Trading Statement

 

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, provides a trading update for the 12 months ended 30 June 2019.

The Board is pleased to announce that the Group has traded strongly and results are in line with expectations for the full year.

Revenue increased by 21% to c. £13m in FY2019 (FY2018: £10.7m) and profit before tax is expected to be in line with expectations, more than doubling from last year (FY2018: £0.67m). Gross margins improved significantly, with a c.500bps increase year-on-year as a result of our strong focus on stock and supply chain optimisation.The growth in profit reflects the agility of our business model, which enables us to scale our stable of brands without incurring corresponding increases in overheads.

All our brands performed well and delivered both revenue and profit growth in the period under review. Skinny Tan in particular contributed strongly, driven by innovative new product launches including "Wonder Serum" and "Protect and Glow" at premium price points and the significant increase in the retail footprint for our core brand which is now available in 2,300 retail stores (FY2018: 1,000) including Boots, Superdrug, and Asda.

The Group's balance sheet has strengthened during the period with strong cash generation from retail customers increasing stock cover and continued working capital controls. This has led to better than expected cash position in excess of £1.7m.

The Company will announce its final results in September 2019.

Haris Chaudhry, Executive Chairman of InnovaDerma said:

"I am very pleased to report our full-year revenue will reflect growth of approximately 21% and we expect PBT to be in line with expectations with profit more than doubling from last year. The Group has made excellent progress during the year, delivered a strong financial and operational performance, which demonstrates our scalable business model and resilience in a challenging retail market. Going forward, we will be focused on product innovation, launching our brands in new territories and entering into new categories with new product launches; the combination of which we believe will further accelerate growth during the new FY. The Board is very excited for the future and the opportunities which lie ahead."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 Further enquiries

 

InnovaDerma

Haris Chaudhry/Joe Bayer

Kieran Callan c/o TB Cardew

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/Giles Rolls/Kate Bannatyne

Alice Lane Ð Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Joe McGregor

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKDDPOBKDKOK
Date   Source Headline
9th Oct 20195:14 pmRNSNotice of AGM & Annual Report
24th Sep 20197:00 amRNSFinal Results
3rd Sep 20197:00 amRNSNotice of Results
19th Aug 20197:00 amRNSHolding(s) in Company
30th Jul 201912:12 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSTrading Statement
13th May 201911:42 amRNSDirector/PDMR Shareholding
26th Apr 201912:34 pmRNSDirector/PDMR Shareholding
27th Feb 201911:06 amRNSDirector/PDMR Shareholding
21st Feb 20197:00 amRNSHalf-year Report
10th Jan 20197:00 amRNSTrading Statement
31st Dec 20187:00 amRNSNotice of Trading Update and Half-Year Results
16th Nov 20183:52 pmRNSDirector/PDMR Shareholding
7th Nov 20184:40 pmRNSSecond Price Monitoring Extn
7th Nov 20184:35 pmRNSPrice Monitoring Extension
7th Nov 20182:05 pmRNSSecond Price Monitoring Extn
7th Nov 20182:00 pmRNSPrice Monitoring Extension
7th Nov 201811:05 amRNSSecond Price Monitoring Extn
7th Nov 201811:00 amRNSPrice Monitoring Extension
7th Nov 201810:41 amRNSResult of Annual General Meeting
7th Nov 20189:05 amRNSSecond Price Monitoring Extn
7th Nov 20189:00 amRNSPrice Monitoring Extension
7th Nov 20187:00 amRNSAnnual General Meeting Statement
6th Nov 201812:35 pmRNSHolding(s) in Company
8th Oct 20184:49 pmRNSNotice of AGM & Posting of Annual Report
25th Sep 201811:00 amRNSPrice Monitoring Extension
21st Sep 201811:00 amRNSHolding(s) in Company
21st Sep 201811:00 amRNSHolding(s) in Company
21st Sep 201811:00 amRNSDirector/PDMR Shareholding
19th Sep 20184:41 pmRNSSecond Price Monitoring Extn
19th Sep 20184:35 pmRNSPrice Monitoring Extension
19th Sep 20187:01 amRNSFinal Results
19th Sep 20187:00 amRNSSkinny Tan to be ranged in Boots UK
12th Sep 20181:57 pmRNSExercise of Warrants
8th Aug 20184:40 pmRNSSecond Price Monitoring Extn
8th Aug 20184:35 pmRNSPrice Monitoring Extension
8th Aug 20187:00 amRNSAppointment of CEO and Roots to be ranged in Tesco
19th Jun 20187:00 amRNSTrading Statement
8th May 20183:35 pmRNSDirector/PDMR Shareholding
8th May 20183:35 pmRNSTR-1
8th May 20183:35 pmRNSTR-1
2nd May 20182:05 pmRNSSecond Price Monitoring Extn
2nd May 20182:00 pmRNSPrice Monitoring Extension
2nd May 201811:05 amRNSSecond Price Monitoring Extn
2nd May 201811:00 amRNSPrice Monitoring Extension
1st May 20184:41 pmRNSSecond Price Monitoring Extn
1st May 20184:35 pmRNSPrice Monitoring Extension
1st May 20183:42 pmRNSLaunch of Prolong in the US and Australia
29th Mar 20184:40 pmRNSSecond Price Monitoring Extn
29th Mar 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.